Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pennant GroupPNTG -0.36%89 3-Year EBITDA Growth Rate is 43.40% as of Jun. 2026, which is 393% above its 10-year median of 8.80. GuruFocus rates PNTG with a GF Score™ of 89/100 and a GF Value™ of $36.72 (Fairly Valued). The stock has 8 warning signs investors should review. Among 526 Healthcare Providers & Services companies, Pennant Group ranks better than 88.02% on this metric.
During the past 12 months, Pennant Group's average EBITDA Per Share Growth Rate was 36.00% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 43.40% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 29.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Pennant Group was 65.00% per year. The lowest was -28.40% per year. And the median was 8.80% per year.
Pennant Group (NAS:PNTG) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Pennant Group 3-Year EBITDA Growth Rate Related Terms
PNTG vs ARDT, HCSG, INNV: 3-Year EBITDA Growth Rate Comparison
For the Medical Care Facilities subindustry, Pennant Group's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pennant Group 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pennant Group's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Pennant Group's 3-Year EBITDA Growth Rate falls into.
Pennant Group 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 43.40% mean?
Pennant Group (PNTG) has a 3-Year EBITDA Growth Rate of 43.40% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Pennant Group and its competitors. This is 393% above median its historical median of 8.80. According to the industry distribution chart, Pennant Group ranks #63 out of 526 companies in the Healthcare Providers & Services industry, placing it in the top 12%.
Is Pennant Group's 3-Year EBITDA Growth Rate too high?
Pennant Group's current 3-Year EBITDA Growth Rate of 43.40% is 393% above median its 10-year median of 8.80. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 10.20. Pennant Group's value of 43.40% is 325.5% above this industry median. Based on the distribution chart, Pennant Group ranks #63 out of 526 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Pennant Group has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pennant Group's 3-Year EBITDA Growth Rate compare to ARDT and HCSG?
According to the Healthcare Providers & Services industry distribution chart, Pennant Group ranks #63 out of 526 companies for 3-Year EBITDA Growth Rate. This places Pennant Group in the top 12% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 10.20. Pennant Group's value of 43.40% is 325.5% above this benchmark. While the company's 10-year median is 8.80 vs. the industry median of 10.20, Pennant Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.20, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pennant Group's current 3-Year EBITDA Growth Rate of 43.40% is 325.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Pennant Group and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pennant Group's current 3-Year EBITDA Growth Rate is 43.40%, which is 393% above median its own 10-year median of 8.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pennant Group stock overvalued right now?
Based on GuruFocus' analysis, Pennant Group (PNTG) is currently considered Fairly Valued. The stock's GF Value™ is $36.72, compared to a current price of $39.18 — trading 6.7% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 43.40%, which is 393% above median its 10-year median of 8.80 and 325.5% above the Healthcare Providers & Services industry median of 10.20. Pennant Group's overall GF Score™ is 89/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Pennant Group (PNTG), the current 3-Year EBITDA Growth Rate is 43.40% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pennant Group (PNTG) Overvalued in 2026?
Based on GuruFocus' analysis, Pennant Group stock appears to be overvalued.
The current stock price of $39.18 is trading 6.7% above its estimated GF Value™ of $36.72.
GuruFocus considers Pennant Group to be Fairly Valued.
Key valuation signals for PNTG:
3-Year EBITDA Growth Rate: 43.40% (393% above median its 10-year median of 8.80)
GF Value™: $36.72 vs. price of $39.18 (6.7% above fair value)
Industry Position: 325.5% above the Healthcare Providers & Services median (#63 of 526)
No single metric tells the full story. See the PNTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
89GF Score
Get the complete analysis for PNTG
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PNTG has been successfully added to your 
